Search results
Results from the WOW.Com Content Network
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
The journal publishes peer-reviewed scholarly articles, notes, reports, and book reviews. It is currently edited by Jos Dute, [3] Herman Nys (Editor-in-chief), [4] and Henriette Roscam Abbing. [5] It is the official journal of the European Association of Health Law. [6]
The European Respiratory Review is published quarterly and focuses on state-of-the-art reviews, updates, editorials and correspondence on current topical issues in respiratory medicine, science and surgery. Its chief editor is Renata Riha. ERJ Open Research is an open access research journal, launched in 2015. [4] Its chief editor is Esther ...
The European Respiratory Journal is a monthly peer-reviewed medical journal covering respirology. It was established in 1988 and is published by the European Respiratory Society, of which it is the official journal. The editor-in-chief is James D. Chalmers (University of Dundee).
This list of law journals includes notable academic periodicals on law. The law reviews are grouped by jurisdiction or country and then into subject areas. This is a dynamic list and may never be able to satisfy particular standards for completeness.
EUR-Lex is the official online database of European Union law and other public documents of the European Union (EU), published in 24 official languages of the EU. The Official Journal (OJ) of the European Union is also published on EUR-Lex. Users can access EUR-Lex free of charge and also register for a free account, which offers extra features.
This page was last edited on 16 November 2024, at 08:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.